Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

BioLineRx gets NASH candidate from Hadasit; contributes to Novartis collaboration

Executive Summary

Hadasit Ltd., the tech transfer unit of Hadassah Medical Organization, granted BioLineRx Ltd. exclusive global rights to a preclinical candidate for liver fibrosis, specifically including nonalcoholic steatohepatitis (NASH). BioLineRx named the project BL1210.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)

Related Companies